Literature DB >> 11058765

Human tear lipocalin.

B Redl1.   

Abstract

Human tear prealbumin, now called tear lipocalin, was originally described as a major protein of human tear fluid, which was thought to be tear specific. However, recent investigations demonstrated that it is identical with lingual von Ebner's gland protein, and is also produced in prostate, nasal mucosa and tracheal mucosa. Homologous proteins have been found in rat, pig and probably dog and horse. Tear lipocalin is an unusual lipocalin member, because of its high promiscuity for relative insoluble lipids and binding characteristics that differ from other members. In addition, it shows inhibitory activity on cysteine proteinases similar to cystatins, a feature unique among lipocalins. Although it acts as the principal lipid binding protein in tear fluid, a more general physiological function has to be proposed due to its wide distribution and properties. It would be ideally suited for scavenging of lipophilic, potentially harmful substances and thus might act as a general protection factor of epithelia.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11058765     DOI: 10.1016/s0167-4838(00)00142-4

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  31 in total

1.  Characterization of the seminal plasma proteome in men with prostatitis by mass spectrometry.

Authors:  Daniel Kagedan; Irene Lecker; Ihor Batruch; Christopher Smith; Ilia Kaploun; Kirk Lo; Ethan Grober; Eleftherios P Diamandis; Keith A Jarvi
Journal:  Clin Proteomics       Date:  2012-02-06       Impact factor: 3.988

2.  Immunohistochemical analysis of secretoglobin SCGB 2A1 expression in human ocular glands and tissues.

Authors:  Mechthild Stoeckelhuber; Elisabeth M Messmer; Corina Schmidt; Fei Xiao; Christoph Schubert; Jörg Klug
Journal:  Histochem Cell Biol       Date:  2006-01-04       Impact factor: 4.304

Review 3.  Antimicrobial compounds in tears.

Authors:  Alison M McDermott
Journal:  Exp Eye Res       Date:  2013-07-20       Impact factor: 3.467

4.  A new crystal form of human tear lipocalin reveals high flexibility in the loop region and induced fit in the ligand cavity.

Authors:  Daniel A Breustedt; Lorenz Chatwell; Arne Skerra
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2009-09-16

Review 5.  The international workshop on meibomian gland dysfunction: report of the subcommittee on tear film lipids and lipid-protein interactions in health and disease.

Authors:  Kari B Green-Church; Igor Butovich; Mark Willcox; Douglas Borchman; Friedrich Paulsen; Stefano Barabino; Ben J Glasgow
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-03-30       Impact factor: 4.799

6.  Comparative proteome analysis of the tear samples in patients with low-grade keratoconus.

Authors:  Fatih Yenihayat; Özgül Altıntaş; Murat Kasap; Gürler Akpınar; Nil Güzel; Onur Sinan Çelik
Journal:  Int Ophthalmol       Date:  2017-08-07       Impact factor: 2.031

Review 7.  Sjögren's syndrome--study of autoantigens and autoantibodies.

Authors:  John G Routsias; Athanasios G Tzioufas
Journal:  Clin Rev Allergy Immunol       Date:  2007-06       Impact factor: 8.667

8.  Microarray analysis of the rat lacrimal gland following the loss of parasympathetic control of secretion.

Authors:  Doan H Nguyen; Hiroshi Toshida; Jill Schurr; Roger W Beuerman
Journal:  Physiol Genomics       Date:  2004-06-17       Impact factor: 3.107

9.  Human tear lipocalin exhibits antimicrobial activity by scavenging microbial siderophores.

Authors:  Maria Fluckinger; Hubertus Haas; Petra Merschak; Ben J Glasgow; Bernhard Redl
Journal:  Antimicrob Agents Chemother       Date:  2004-09       Impact factor: 5.191

10.  Lipids including cholesteryl linoleate and cholesteryl arachidonate contribute to the inherent antibacterial activity of human nasal fluid.

Authors:  Thai Q Do; Safiehkhatoon Moshkani; Patricia Castillo; Suda Anunta; Adelina Pogosyan; Annie Cheung; Beth Marbois; Kym F Faull; William Ernst; Su Ming Chiang; Gary Fujii; Catherine F Clarke; Krishna Foster; Edith Porter
Journal:  J Immunol       Date:  2008-09-15       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.